evaluate the digital health company amwell on wegovy / semaglutide (Semaglutide) for Weight Loss - FDA-Approved GLP-1 Wegovy (Semaglutide) Weight Loss Injection

This minimally invasive treatment delivers youthful, radiant results with customizable options and minimal downtime

In March 2024, the FDA approved Wegovy to reduce the risk of cardiovascular events, stroke, and heart attack in adults with cardiovascular disease and either obesity or overweight

When you decide to Start Your Treatment with us, you're choosing a clear, predictable, and affordable path to the same active ingredients found in brand-name injections

Visit JSJ Aesthetics in Salem, NH, for personalized vitamin injections that replenish essential nutrients and restore vitality

A 5 mg vial reconstituted with bacteriostatic water yields about 1.67 mg/mL